Parkman Healthcare Partners LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $708 Million distributed in 93 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $37.5M, Insulet Corp with a value of $37.2M, Eli Lilly & CO with a value of $35.8M, Keros Therapeutics, Inc. with a value of $24.5M, and Teleflex Inc with a value of $23.8M.

Examining the 13F form we can see an increase of $30.4M in the current position value, from $678M to 708M.

Parkman Healthcare Partners LLC is based out at Stamford, CT

Below you can find more details about Parkman Healthcare Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $708 Million
Healthcare: $703 Million
Industrials: $5.39 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 93
  • Current Value $708 Million
  • Prior Value $678 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 16 stocks
  • Additional Purchases 38 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 39 stocks
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.